Dopamine receptor stimulating activity of 5-hydroxy-6-methyl-2-aminotetralin derivatives.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Archives internationales de pharmacodynamie et de therapie

• Publication date

  1981-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 6791601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.

  1979cited by this paper
• Dopaminergic effects of non-hydroxylated rigid analogs of apomorphine.

  1979cited by this paper
• Centrally mediated hypotension and bradycardia induced by an aminotetralin derivative: TL-68.

  1978cited by this paper
• Schizophrenic symptoms improve with apomorphine.

  1978cited by this paper
• Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

  1976cited by this paper
• Synthesis and dopaminergic activity of (+/-)-, (+)-, and (-)-2-dipropylamino-5-hydroxy-1,2,3,4-tetrahydronaphthalene.

  1976cited by this paper
• Inhibition of the sympathetic nervous system by 5,6-dihydroxy-2-dimethylamino tetralin (M-7), apomorphine and dopamine.

  1975cited by this paper
• Brain receptors for antipsychotic drugs and dopamine: direct binding assays.

  1975cited by this paper
• Bulbocapnine's ability to antagonize the adrenergic inhibitory action of dopamine and analogs.

  1975cited by this paper

• Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211).

  1990cites this paper
• SK&F 89124, A POTENT AND SELECTIVE AGONIST AT PREJUNCTIONAL DOPAMINE RECEPTORS

  1989cites this paper
• Introduction of a putative dopaminergic prodrug moiety into a 6,7-substitution pattern characteristic of certain 2-aminotetralin dopaminergic agonists.

  1989cites this paper
• (R)-(-)-10-methyl-11-hydroxyaporphine: a highly selective serotonergic agonist.

  1988cites this paper
• Assessment of a potential dopaminergic prodrug moiety in several ring systems.

  1986cites this paper
• Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.

  1985cites this paper
• Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.

  1985cites this paper
• Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system.

  1985cites this paper
• Dopamine receptors: Functions, subtypes and emerging concepts

  1985cites this paper
• Dopamine agonists: structure-activity relationships.

  1985cites this paper
• In vivo and in vitro dopaminergic effects of three ergoline fragments

  1984cites this paper
• Possible biologically active metabolites of 5-hydroxy-6-methyl-2-di-n-propylaminotetralin.

  1984cites this paper
• Structure-activity relationships of dopamine agonists.

  1983cites this paper
• Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications.

  1982cites this paper
• Future directions in dopaminergic nervous system and dopaminergic agonists.

  1981cites this paper